PAR 1.92% 26.5¢ paradigm biopharmaceuticals limited..

Chart, page-3953

  1. 9,655 Posts.
    lightbulb Created with Sketch. 1231
    They are reporting MRI results per 1 Sept 2023 ASX:

    Upcoming news flow:

    • The quantitative analysis of MRI results from the day 168 timepoint of
    PARA_OA_008 is also expected to be reported in September 2023. Previously,
    Paradigm reported a semi-quantitative analysis of the structural observations
    following iPPS compared to placebo on cartilage volume, bone marrow lesions
    and marginal osteophytes. The quantitative analysis will provide further detailed
    determination of the structural changes occurring in the joint following iPPS
    compared to placebo.



    Reverting back to baseline at 12 months is to be expected IMO. Follow-up treatments 2, 3 etc is when DM benefit is compounding in animals.

    As noted previously the ongoing treatment revenue is likely to overtake the initial patient treatment revenue with a few years of release


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.005(1.92%)
Mkt cap ! $92.69M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $233.3K 883.4K

Buyers (Bids)

No. Vol. Price($)
1 18086 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 1063 4
View Market Depth
Last trade - 15.09pm 28/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.